Milano A, De Carlo M, Pratali S, Barzaghi C, Nardi C, Paterni G, Bellina C R, Mariotti R, Bortolotti U
Cattedra di Cardiochirurgia, Università degli Studi, Pisa.
G Ital Cardiol. 1997 Oct;27(10):1011-8.
Transmyocardial laser revascularization (TMLR) aims to improve perfusion of the ventricular wall via laser-created transmural channels. We present the results of TMLR with a holmium laser as sole therapy in patients with angina refractory to medical treatment and extensive coronary artery disease unsuitable for angioplasty or coronary artery by-pass grafting.
From November 1995 to February 1997, twenty-two patients underwent isolated TMLR with a holmium laser. Five patients (23%) were female; the mean age was 67 +/- 7 years (range 53 to 74 years). Previous myocardial revascularization procedures had been performed in 17 patients (77%). Mean preoperative angina class was 3.4 +/- 0.5 and unstable angina was present in 7 patients (32%).
There were no hospital deaths. The only postoperative complications were transient supraventricular arrhythmias in 6 patients (27%). Each patient received a mean of 33 +/- 8 channels in 27 +/- 13 minutes. There were two late deaths, 40 days and 4 months after TMLR, due to stroke and myocardial infarction, respectively. Mean follow-up duration was 8 +/- 5 months (range 40 days-15 months). The mean number of hospitalizations due to angina fell from 4.9 +/- 1.5 in the 6 months before TMLR to 1.5 +/- 1.0 in the 6 months following surgery (p < 0.001). At follow-up, mean angina class had significantly improved (1.8 +/- 0.6, p < 0.001), as well as effort tolerance, which increased from a mean of 3.5 +/- 1.4 minutes to 5.1 +/- 1.7 minutes (p = 0.01). 201Tl SPECT at 3 and 6 months did not show any significant changes in the segmental perfusion of the lased and unlased areas.
TMLR with a holmium laser is a simple procedure with low operative mortality and morbidity. Short-term results confirm that clinical improvement is obtained in most patients, although this is not supported by significant changes in myocardial perfusion at short-term follow-up.
心肌激光血运重建术(TMLR)旨在通过激光制造的透壁通道改善心室壁灌注。我们报告了将钬激光作为唯一治疗手段,用于药物治疗无效且患有广泛冠状动脉疾病、不适宜进行血管成形术或冠状动脉搭桥术的心绞痛患者的TMLR结果。
1995年11月至1997年2月,22例患者接受了单纯钬激光TMLR治疗。5例(23%)为女性;平均年龄为67±7岁(范围53至74岁)。17例(77%)患者曾接受过心肌血运重建手术。术前平均心绞痛分级为3.4±0.5,7例(32%)患者存在不稳定型心绞痛。
无住院死亡病例。术后仅6例(27%)患者出现短暂性室上性心律失常。每位患者平均在27±13分钟内接受了33±8条通道的治疗。有2例晚期死亡病例,分别在TMLR术后40天和4个月,死因分别为中风和心肌梗死。平均随访时间为8±5个月(范围40天至15个月)。因心绞痛住院的平均次数从TMLR术前6个月的4.9±1.5次降至术后6个月的1.5±1.0次(p<0.001)。随访时,平均心绞痛分级显著改善(1.8±0.6,p<0.001),运动耐量也有所提高,从平均3.5±1.4分钟增加到5.1±1.7分钟(p=0.01)。术后3个月和6个月的201Tl单光子发射计算机断层扫描(SPECT)显示,激光照射区域和未照射区域的节段灌注均无显著变化。
钬激光TMLR是一种操作简单、手术死亡率和发病率低的手术。短期结果证实,大多数患者的临床症状得到改善,尽管短期随访时心肌灌注无显著变化支持这一结论。